Table 1.

Laboratory data on admission

Peripheral blood		Blood chemistry		Serological tests
WBC	11,400/μL	TP	7.0 g/dL	Procalcitonin	48.31 ng/mL
Neutro	77.2%	Alb	3.4 g/dL	Hyaluronic acid	27.8 ng/mL
Eos	0.2%	T-Bil	1.1 mg/dL	M2BPGi	(–) 0.52
Baso	0.1%	AST	404 U/L
Mono	9.2%	ALT	418 U/L	Tumor markers
Lymph	13.3%	LDH	919 U/L	AFP	6.9 ng/mL
RBC	428 × 104/μL	ALP	331 U/L	CEA	< 0.5 ng/mL
Hb	12.2 g/dL	γ-GTP	86 U/L	CA19-9	< 2.0 U/mL
Plt	36.5 × 104/μL	Amyl	59 U/L	NSE	8.1 ng/mL
		ChE	251 U/L	ProGRP	17.8 pg/mL
		CK	50 U/L
		T-Chol	144 mg/dL	Endocrine exam
		TG	48 mg/dL	TSH	2.670 µIU/mL
Blood coagulation factors		UN	9.0 mg/dL	FT4	1.29 ng/dL
PT	85.1%	Cr	0.58 mg/dL
APTT	39.6 s	Na	137 mEq/L	Virus markers
Fib	> 800 mg/dL	K	4.0 mEq/L	HBs-Ag	(–)
FDP	6.5 µg/mL	Glu	98 mg/dL	HBc-Ab	(–)
D-dimer	1.5 µg/mL	CRP	19.12 mg/dL	HCV-Ab	(–)

γ-GTP γ-glutamyltransferase, AFP α-fetoprotein, Alb albumin, ALP alkaline phosphatase, ALT alanine aminotransferase, Amyl amylase, APTT activated partial thromboplastin time, AST aspartate aminotransferase, Baso basophils, CA19-9 carbohydrate antigen 19–9, CEA carcinoembryonic antigen, ChE: cholinesterase, CK creatine kinase, Cr creatinine, CRP C-reactive protein, Eos eosinophils, FDP fibrin/fibrinogen degradation products, Fib fibrinogen, FT4 free thyroxine, Glu glucose, Hb hemoglobin, HBc-Ab hepatitis B core antibody, HBs-Ag hepatitis B surface antigen, HCV-RNA hepatitis C virus RNA, K potassium, Lymph lymphocytes, LDH lactate dehydrogenase, Mono monocytes, M2BPGi Mac2-binding Protein Glucosylation Isomer, Na sodium, Neutro neutrophils, NSE neuron-specific enolase, P-Amyl pancreatic amylase, Plt platelet count, ProGRP pro-gastrin-releasing peptide, PT prothrombin time, RBC: red blood cell count, T-Bil total bilirubin, T-Chol total cholesterol, TG triglycerides, TP total protein, TSH thyroid-stimulating hormone, UN urea nitrogen, WBC white blood cell count